Aurobindo Pharma Limited
AUROPHARMA
Kedudukan dalam Saham
#2074
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Harga Saham
$17.34
Modal Pasaran
$9.98B
Perubahan (1 hari)
-3.08%
Perubahan (1 tahun)
38.71%
Negara
IN
Perdagangan Aurobindo Pharma Limited (AUROPHARMA)
Kategori
Healthcare
Nisbah P/B bagi Aurobindo Pharma Limited (AUROPHARMA)
Nisbah P/B pada October 2026 TTM: 2.57
Menurut laporan kewangan dan harga saham terkini Aurobindo Pharma Limited, nisbah P/B semasa (TTM) ialah 2.57. Pada akhir 2024, nisbah P/B syarikat ialah 2.19.
Sejarah nisbah P/B untuk Aurobindo Pharma Limited dari 2004 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| 2026 (TTM) | 2.57 | 27.04% |
| 2025 | 2.02 | -7.39% |
| 2024 | 2.19 | 93.26% |
| 2023 | 1.13 | -29.04% |
| 2022 | 1.59 | -32.31% |
| 2021 | 2.35 | 63.66% |
| 2020 | 1.44 | -56.95% |
| 2019 | 3.34 | 12.45% |
| 2018 | 2.97 | -29.51% |
| 2017 | 4.22 | -31.63% |
| 2016 | 6.17 | -10.73% |
| 2015 | 6.91 | 73.88% |
| 2014 | 3.97 | 134.01% |
| 2013 | 1.70 | 14.65% |
| 2012 | 1.48 | -35.83% |
| 2011 | 2.31 | -18.76% |
| 2010 | 2.84 | 248.60% |
| 2009 | 0.81 | -41.39% |
| 2008 | 1.39 | -65.94% |
| 2007 | 4.08 | -7.24% |
| 2006 | 4.40 | 114.42% |
| 2005 | 2.05 | -17.12% |
| 2004 | 2.48 | 0.00% |
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 96.44% |
IN
|
